You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
泰凌醫藥(01011.HK) : 蘇州第壹製藥重整已確認未償還債務逾6億元人幣
阿思達克 09-15 09:00
泰凌醫藥(01011.HK)公布,有關蘇州第壹製藥重整,經債權人權利申報及相關部門審核確認,已確認未償還債務約6.12億元人民幣(下同),而待審核確認債務約1.79億元。 公司指,重整計劃完成後,資產及負債總額將減少,但有能力繼續開展業務營運,並按上市規則的要求,保持足夠業務運作及擁有相當價值的資產。 公司表示,以往是中國最大的疫苗供應及銷售服務商,今年起,已戰略性地調整主要重點及分配資源,打造為領先的「骨健康全程治療與管理平台」,將充分利用核心能力及資源,以滿足整個骨骼相關醫療需求。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account